ABU DHABI: A real-world evidence study on the results of AstraZeneca’s Evusheld in protecting immunocompromised patients in the UAE from symptomatic COVID-19 has been launched in Abu Dhabi, the Emirates News Agency reported. The study aims to offer critical data on the safety and efficacy of the long-acting antibody combination and is one of the many outcomes of a
Emirates News Agency - Abu Dhabi witnesses launch of real-world evidence study to assess AstraZeneca s Evusheld wam.ae - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wam.ae Daily Mail and Mail on Sunday newspapers.
ABU DHABI, 28th March, 2022 (WAM) Department of Health – Abu Dhabi (DoH), the regulator of the healthcare sector in the Emirate, Pure Health, the largest integrated healthcare platform in the UAE, and G42 Healthcare, Abu Dhabi based leading health tech company, signed a Memorandum of Understanding (MoU) to establish the Centre of Digital Health (CDH) in the Emirate of Abu Dhabi.
The centre seeks to develop robust data platforms and accelerate digital services that elevate the healthcare sector, thereby reiterating the emirate’s position.